Michael Milos Thornton Buys 30,000 Shares of ENDRA Life Sciences Inc (NDRA) Stock

ENDRA Life Sciences Inc (NASDAQ:NDRA) insider Michael Milos Thornton purchased 30,000 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was acquired at an average cost of $1.13 per share, with a total value of $33,900.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

NASDAQ:NDRA opened at $1.20 on Wednesday. ENDRA Life Sciences Inc has a 1 year low of $1.00 and a 1 year high of $5.75.

ENDRA Life Sciences (NASDAQ:NDRA) last released its quarterly earnings results on Monday, March 11th. The company reported ($0.28) earnings per share (EPS) for the quarter.

Large investors have recently added to or reduced their stakes in the company. National Asset Management Inc. bought a new position in shares of ENDRA Life Sciences in the fourth quarter worth $35,000. Virtu Financial LLC grew its stake in shares of ENDRA Life Sciences by 109.2% in the first quarter. Virtu Financial LLC now owns 28,602 shares of the company’s stock worth $47,000 after purchasing an additional 14,930 shares in the last quarter. Creative Planning bought a new position in shares of ENDRA Life Sciences in the fourth quarter worth $53,000. Geode Capital Management LLC bought a new position in shares of ENDRA Life Sciences in the fourth quarter worth $71,000. Finally, ICM Asset Management Inc. WA grew its stake in shares of ENDRA Life Sciences by 412.9% in the fourth quarter. ICM Asset Management Inc. WA now owns 671,226 shares of the company’s stock worth $1,007,000 after purchasing an additional 540,356 shares in the last quarter. 19.00% of the stock is owned by institutional investors.

Separately, Lake Street Capital began coverage on ENDRA Life Sciences in a research note on Monday. They issued a “buy” rating for the company.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/05/22/michael-milos-thornton-buys-30000-shares-of-endra-life-sciences-inc-ndra-stock.html.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.

Further Reading: How is the S&P 500 index different from the DJIA?

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.